QuantaMatrix Incorporated — Investor Relations & Filings
QuantaMatrix Incorporated is an in-vitro diagnostics (IVD) company specializing in the development and manufacturing of medical devices using microbial diagnostics technology. The company focuses on providing rapid diagnostic solutions for critical conditions, with a primary emphasis on sepsis. Its flagship product, dRAST™ (direct & Rapid Antimicrobial Susceptibility Test), significantly reduces the time for determining effective antibiotics for sepsis patients, providing results in as few as four hours from a positive blood culture, compared to several days for conventional methods. This technology, which utilizes microfluidic channels and time-lapse microscopic imaging, enables faster, targeted antimicrobial therapy. In addition to sepsis, QuantaMatrix develops diagnostic solutions for other areas, including tuberculosis (QDST™), Alzheimer's disease (QPLEX™), and cardiovascular diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 분기보고서 (2022.09) | 2022-11-14 | Korean | |
| 기타경영사항(자율공시)(외국인 지분율 일부 변동 안내) | 2022-11-11 | Korean | |
| [기재정정]기타경영사항(자율공시)(외국인 지분율 일부 변동 안내) | 2022-11-11 | Korean | |
| 소송등의판결ㆍ결정(신주발행무효확인) | 2022-10-27 | Korean | |
| 반기보고서 (2022.06) | 2022-08-16 | Korean | |
| 분기보고서 (2022.03) | 2022-05-16 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
14 filings
| |||||
| 8580720 | 분기보고서 (2022.09) | 2022-11-14 | Korean | ||
| 8587964 | 기타경영사항(자율공시)(외국인 지분율 일부 변동 안내) | 2022-11-11 | Korean | ||
| 8587897 | [기재정정]기타경영사항(자율공시)(외국인 지분율 일부 변동 안내) | 2022-11-11 | Korean | ||
| 8596704 | 소송등의판결ㆍ결정(신주발행무효확인) | 2022-10-27 | Korean | ||
| 8633457 | 반기보고서 (2022.06) | 2022-08-16 | Korean | ||
| 8695926 | 분기보고서 (2022.03) | 2022-05-16 | Korean | ||
| 8732496 | 정기주주총회결과 | 2022-03-31 | Korean | ||
| 8747002 | 감사보고서제출 | 2022-03-23 | Korean | ||
| 8746967 | 사업보고서 (2021.12) | 2022-03-23 | Korean | ||
| 8774802 | 주주총회소집공고 | 2022-03-16 | Korean | ||
| 8774384 | 주주총회집중일개최사유신고 | 2022-03-16 | Korean | ||
| 8779659 | 주주총회소집결의 | 2022-03-15 | Korean | ||
| 8779522 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2022-03-15 | Korean | ||
| 8831608 | 주식등의대량보유상황보고서(일반) | 2022-01-21 | Korean | ||
|
2021
1 filing
| |||||
| 8852984 | 주주명부폐쇄기간또는기준일설정 | 2021-12-15 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
QuantaMatrix Incorporated via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15060/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15060 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15060 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15060 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15060}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for QuantaMatrix Incorporated (id: 15060)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.